Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA reform reprise in 105th Congress planned by industry groups and House Republicans.

Executive Summary

FDA REFORM REPRISE IN 105th CONGRESS IS PLANNED by industry trade groups and the Republican House leadership. House Commerce/Oversight Subcommittee Chairman Barton (R-Tex.) expressed the Republican House leadership interest in comments to a medical device manufacturers meeting in Seattle on Sept. 16. "There's no reason we couldn't [re-introduce] this bill in early January," and put it on a fast legislative track, Barton declared.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS028876

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel